首页> 外文期刊>Lipids in Health Disease >The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats
【24h】

The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats

机译:大蒜素和非诺贝特联合治疗对高脂饮食诱导的大鼠血管内皮功能障碍和肝损伤的影响

获取原文
获取外文期刊封面目录资料

摘要

Background It is designed to investigate the effects of combination therapy of allicin and fenofibrate on the endothelial and liver functions in rats with hyperlipidemia. Methods The healthy male Wistar rats fed high fat diet were treated with fenofibrate (80 mg/kg per day) alone, allicin (60 mg/kg per day) alone and a lower dasage of combined therapy (allicin 20 mg/kg per day and fenofibrate 30 mg/kg per day) respectively for 8 weeks. The serum levels of cholesterol, triglyceride, nitrogen oxidative, alanine transferase (ALT) and aspartate transferase (AST) were determined. Acetylcholine-induced endothelium-dependent vascular relaxation (EDVR) of aorta rings was tested, and the morphologic changes of liver tissue were observed. Results Compared with high fat diet control, fenofibrate alone or the combined therapy increased remarkably the levels of high density lipoprotein respectively (P < 0.05). Both single and combined therapy of fenofibrate and allicin significantly enhanced the levels of NO (P < 0.01 or P < 0.05), but the combined therapy had greatest high EDVR responses (P < 0.01). Furthermore, the reduced levels of ALT and AST were significantly obvious in the combined therapy groups (P < 0.01 or P < 0.05). In addition, the lower dosage of combined therapy significantly ameliorated severe fatty degeneration of liver cells occurred in the high fat diet fed rat although the single fenofibrate treatment showed spotty necrosis of liver cells and bile duct expansion. Conclusion Combination therapy with allicin and fenofibrate can effectively enhance the protective effects on endothelial function and reduce the hepatic damage in rats with hyperlipidemia.
机译:背景技术旨在研究大蒜素和非诺贝特联合治疗对高脂血症大鼠内皮和肝功能的影响。方法饲喂高脂饮食的健康雄性Wistar大鼠单独用非诺贝特(80 mg / kg /天),单独用大蒜素(60 mg / kg /天)和较低的联合治疗剂量(allicin 20 mg / kg /天)治疗。非诺贝特30 mg / kg每天),持续8周。测定血清中的胆固醇,甘油三酸酯,氮氧化,丙氨酸转移酶(ALT)和天冬氨酸转移酶(AST)的水平。测试了乙酰胆碱引起的主动脉环内皮依赖性血管舒张(EDVR),并观察了肝脏组织的形态变化。结果与高脂饮食对照组相比,单独使用非诺贝特或联合使用非诺贝特显着提高了高密度脂蛋白水平(P <0.05)。非诺贝特和大蒜素的单一和联合治疗均显着提高了NO水平(P <0.01或P <0.05),但联合治疗对EDVR的反应最大(P <0.01)。此外,在联合治疗组中,ALT和AST的降低水平也很明显(P <0.01或P <0.05)。此外,低剂量的联合疗法可显着改善高脂饮食喂养大鼠的肝细胞严重脂肪变性,尽管单次非诺贝特治疗显示肝细胞斑点坏死和胆管扩张。结论大蒜素与非诺贝特联合治疗可有效增强高脂血症大鼠对内皮功能的保护作用,减轻肝损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号